Information Provided By:
Fly News Breaks for May 31, 2017
CDXS
May 31, 2017 | 06:17 EDT
Jefferies analyst Brandon Couillard started Codexis with a Buy rating and $8 price target. The company is an expert in protein engineering and custom enzymes used in commercial manufacturing, Couillard tells investors in a research note. He views Codexis as an "under-appreciated small-cap growth idea."
News For CDXS From the Last 2 Days
There are no results for your query CDXS